Nitric oxide modulates right ventricular flow and oxygen consumption during norepinephrine infusion

Srinath Setty, Johnathan D. Tune, H. Fred Downey

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

This study was designed to test if nitric oxide (NO) contributes to norepinephrine-induced right coronary vasodilation and if NO blunts the norepinephrine-induced increase in myocardial oxygen consumption (MVO2) in the right ventricle. In five anesthetized, open-chest dogs, mean aortic pressure, heart rate, right ventricular rate of pressure development over time (dP/dt), right coronary blood flow, and right ventricular MVO2 were measured before and during graded intracoronary infusions of norepinephrine in the absence and presence of a NO synthase blocker, Nω-nitro-L-arginine methyl ester (L-NAME; 150 μg/min ic). During both conditions, right coronary blood flow and right ventricular MVO2 significantly increased with graded infusions of norepinephrine. L-NAME significantly blunted the coronary hyperemic response to norepinephrine, although L-NAME did not alter the relationship between right ventricular MVO2 and norepinephrine dose. However, when right ventricular function was indexed by heart rate × right ventricular maximum dP/dt × peak right ventricular systolic pressure, L-NAME significantly increased the oxygen cost of right ventricular function. These results indicate that NO contributes to norepinephrine-induced right coronary vasodilation and improves right ventricular oxygen utilization efficiency.

Original languageEnglish (US)
Pages (from-to)H696-H703
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume282
Issue number2 51-2
StatePublished - Jun 29 2002

Fingerprint

Oxygen Consumption
Norepinephrine
Nitric Oxide
NG-Nitroarginine Methyl Ester
Right Ventricular Function
Ventricular Pressure
Vasodilation
Heart Rate
Oxygen
Nitric Oxide Synthase
Heart Ventricles
Arterial Pressure
Thorax
Dogs
Blood Pressure
Costs and Cost Analysis

Keywords

  • N-nitro-L-arginine methyl ester
  • Open-chest dogs
  • Right coronary circulation
  • Right ventricular oxygen utilization efficiency

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Nitric oxide modulates right ventricular flow and oxygen consumption during norepinephrine infusion. / Setty, Srinath; Tune, Johnathan D.; Downey, H. Fred.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 282, No. 2 51-2, 29.06.2002, p. H696-H703.

Research output: Contribution to journalArticle

@article{a61c463e46a94a539876c0ad2ec4bd0f,
title = "Nitric oxide modulates right ventricular flow and oxygen consumption during norepinephrine infusion",
abstract = "This study was designed to test if nitric oxide (NO) contributes to norepinephrine-induced right coronary vasodilation and if NO blunts the norepinephrine-induced increase in myocardial oxygen consumption (MVO2) in the right ventricle. In five anesthetized, open-chest dogs, mean aortic pressure, heart rate, right ventricular rate of pressure development over time (dP/dt), right coronary blood flow, and right ventricular MVO2 were measured before and during graded intracoronary infusions of norepinephrine in the absence and presence of a NO synthase blocker, Nω-nitro-L-arginine methyl ester (L-NAME; 150 μg/min ic). During both conditions, right coronary blood flow and right ventricular MVO2 significantly increased with graded infusions of norepinephrine. L-NAME significantly blunted the coronary hyperemic response to norepinephrine, although L-NAME did not alter the relationship between right ventricular MVO2 and norepinephrine dose. However, when right ventricular function was indexed by heart rate × right ventricular maximum dP/dt × peak right ventricular systolic pressure, L-NAME significantly increased the oxygen cost of right ventricular function. These results indicate that NO contributes to norepinephrine-induced right coronary vasodilation and improves right ventricular oxygen utilization efficiency.",
keywords = "N-nitro-L-arginine methyl ester, Open-chest dogs, Right coronary circulation, Right ventricular oxygen utilization efficiency",
author = "Srinath Setty and Tune, {Johnathan D.} and Downey, {H. Fred}",
year = "2002",
month = "6",
day = "29",
language = "English (US)",
volume = "282",
pages = "H696--H703",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "2 51-2",

}

TY - JOUR

T1 - Nitric oxide modulates right ventricular flow and oxygen consumption during norepinephrine infusion

AU - Setty, Srinath

AU - Tune, Johnathan D.

AU - Downey, H. Fred

PY - 2002/6/29

Y1 - 2002/6/29

N2 - This study was designed to test if nitric oxide (NO) contributes to norepinephrine-induced right coronary vasodilation and if NO blunts the norepinephrine-induced increase in myocardial oxygen consumption (MVO2) in the right ventricle. In five anesthetized, open-chest dogs, mean aortic pressure, heart rate, right ventricular rate of pressure development over time (dP/dt), right coronary blood flow, and right ventricular MVO2 were measured before and during graded intracoronary infusions of norepinephrine in the absence and presence of a NO synthase blocker, Nω-nitro-L-arginine methyl ester (L-NAME; 150 μg/min ic). During both conditions, right coronary blood flow and right ventricular MVO2 significantly increased with graded infusions of norepinephrine. L-NAME significantly blunted the coronary hyperemic response to norepinephrine, although L-NAME did not alter the relationship between right ventricular MVO2 and norepinephrine dose. However, when right ventricular function was indexed by heart rate × right ventricular maximum dP/dt × peak right ventricular systolic pressure, L-NAME significantly increased the oxygen cost of right ventricular function. These results indicate that NO contributes to norepinephrine-induced right coronary vasodilation and improves right ventricular oxygen utilization efficiency.

AB - This study was designed to test if nitric oxide (NO) contributes to norepinephrine-induced right coronary vasodilation and if NO blunts the norepinephrine-induced increase in myocardial oxygen consumption (MVO2) in the right ventricle. In five anesthetized, open-chest dogs, mean aortic pressure, heart rate, right ventricular rate of pressure development over time (dP/dt), right coronary blood flow, and right ventricular MVO2 were measured before and during graded intracoronary infusions of norepinephrine in the absence and presence of a NO synthase blocker, Nω-nitro-L-arginine methyl ester (L-NAME; 150 μg/min ic). During both conditions, right coronary blood flow and right ventricular MVO2 significantly increased with graded infusions of norepinephrine. L-NAME significantly blunted the coronary hyperemic response to norepinephrine, although L-NAME did not alter the relationship between right ventricular MVO2 and norepinephrine dose. However, when right ventricular function was indexed by heart rate × right ventricular maximum dP/dt × peak right ventricular systolic pressure, L-NAME significantly increased the oxygen cost of right ventricular function. These results indicate that NO contributes to norepinephrine-induced right coronary vasodilation and improves right ventricular oxygen utilization efficiency.

KW - N-nitro-L-arginine methyl ester

KW - Open-chest dogs

KW - Right coronary circulation

KW - Right ventricular oxygen utilization efficiency

UR - http://www.scopus.com/inward/record.url?scp=0036087586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036087586&partnerID=8YFLogxK

M3 - Article

C2 - 11788420

AN - SCOPUS:0036087586

VL - 282

SP - H696-H703

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 2 51-2

ER -